PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
High Affinity Nerve Growth Factor Receptor 47 Target Disease Cancer 1,053,491 1 0.00 -0.99 0.02 0.51
Mu Opioid Receptor 4,576 Target Disease Cancer 1,053,491 93 0.00 -0.99 0.02 0.52
Beta-Glucosidase 4,297 Target Disease Cancer 1,053,491 74 0.00 -0.99 0.02 0.51
Beta-Secretase 1 59 Target Disease Cancer 1,053,491 1 0.00 -0.99 0.02 0.51
Ns3 3,189 Target Disease Cancer 1,053,491 40 0.00 -0.99 0.01 0.50
CNTF 1,613 Target Disease Cancer 1,053,491 17 0.00 -0.99 0.01 0.50
ApoE2 517 Target Disease Cancer 1,053,491 5 0.00 -1.00 0.01 0.50
Adenosine A1 Receptor 1,432 Target Disease Cancer 1,053,491 6 0.00 -1.00 0.00 0.48
CSF2/GM-CSF 2 Target Disease Infection 766,637 1 0.00 -0.71 0.50 0.57
Ns3 3,189 Target Disease Infection 766,637 1,156 0.02 -0.80 0.36 0.61
CD4 112,219 Target Disease Infection 766,637 30,996 0.11 -0.83 0.28 0.68
CCL7 274 Target Disease Infection 766,637 48 0.00 -0.91 0.18 0.57
Retinoic Acid Receptor Gamma-1 6 Target Disease Infection 766,637 1 0.00 -0.91 0.17 0.55
Hiv-1 Integrase 1,199 Target Disease Infection 766,637 180 0.01 -0.92 0.15 0.58
CCL19 658 Target Disease Infection 766,637 97 0.00 -0.92 0.15 0.57
AP2M1 7 Target Disease Infection 766,637 1 0.00 -0.93 0.14 0.55
CD14 9,941 Target Disease Infection 766,637 1,283 0.01 -0.93 0.13 0.59
CD62L/L-Selectin 8 Target Disease Infection 766,637 1 0.00 -0.94 0.12 0.55
BD3 32 Target Disease Infection 766,637 4 0.00 -0.94 0.12 0.55
CXCL7 76 Target Disease Infection 766,637 9 0.00 -0.94 0.12 0.55
Synaptic Vesicle Glycoprotein 2a 9 Target Disease Infection 766,637 1 0.00 -0.94 0.11 0.54
ADRBK1 10 Target Disease Infection 766,637 1 0.00 -0.95 0.10 0.54
4-1BB Receptor 20 Target Disease Infection 766,637 2 0.00 -0.95 0.10 0.55
CD1A 2,739 Target Disease Infection 766,637 240 0.01 -0.96 0.09 0.57
D4-GDI 35 Target Disease Infection 766,637 3 0.00 -0.96 0.09 0.54
CXCL16 341 Target Disease Infection 766,637 27 0.00 -0.96 0.08 0.55
CCL18 256 Target Disease Infection 766,637 18 0.00 -0.96 0.07 0.55
C5a 4,164 Target Disease Infection 766,637 283 0.01 -0.97 0.07 0.56
Complement Component C3c 15 Target Disease Infection 766,637 1 0.00 -0.97 0.07 0.54
CD68 6,424 Target Disease Infection 766,637 425 0.01 -0.97 0.07 0.56
BAFF 1,240 Target Disease Infection 766,637 74 0.00 -0.97 0.06 0.55
Myeloperoxidase 16,181 Target Disease Infection 766,637 896 0.01 -0.97 0.06 0.56
Complement Decay-Accelerating Factor 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
BD2 76 Target Disease Infection 766,637 4 0.00 -0.97 0.05 0.54
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
A1M 59 Target Disease Infection 766,637 3 0.00 -0.97 0.05 0.54
ACTG1 41 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
ASK1 762 Target Disease Infection 766,637 36 0.00 -0.98 0.05 0.54
BAFFR 44 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
ELC 355 Target Disease Infection 766,637 16 0.00 -0.98 0.05 0.54
C4A 1,177 Target Disease Infection 766,637 53 0.00 -0.98 0.05 0.54
Dopamine Receptor D3 45 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
CCL4 5,638 Target Disease Infection 766,637 249 0.00 -0.98 0.04 0.55
High Affinity Nerve Growth Factor Receptor 47 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
BLyS 457 Target Disease Infection 766,637 18 0.00 -0.98 0.04 0.54
Phosphodiesterase 4b 54 Target Disease Infection 766,637 2 0.00 -0.98 0.04 0.53
Penicillin Binding Protein 3 162 Target Disease Infection 766,637 6 0.00 -0.98 0.04 0.53
Epigen 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
DAPK2 27 Target Disease Infection 766,637 1 0.00 -0.98 0.04 0.53
APOH 110 Target Disease Infection 766,637 4 0.00 -0.98 0.04 0.53